Outset Medical, Inc. Operating Cash Flow
Outset Medical, Inc. (OM) reported Operating Cash Flow of -$22.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Outset Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.63M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$12.84M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$9.52M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.32M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$46.33M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$116.30M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$131.37M.
- Outset Medical, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$145.73M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$22.48M 10-Q · filed 2026-08-06 | -$32.00M derived: sum of 3 quarters · filed 2026-08-06 | -$38.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$12.84M 10-Q · filed 2026-05-07 | -$22.36M derived: sum of 2 quarters · filed 2026-05-07 | -$28.68M derived: sum of 3 quarters · filed 2026-05-07 | -$33.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$9.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$15.84M derived: sum of 2 quarters · filed 2026-02-13 | -$20.66M derived: sum of 3 quarters · filed 2026-08-06 | -$46.33M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$6.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$11.14M derived: sum of 2 quarters · filed 2026-08-06 | -$36.81M 10-Q · filed 2025-11-10 | -$53.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$30.49M 10-Q · filed 2026-08-06 | -$46.97M derived: sum of 3 quarters · filed 2026-08-06 | -$67.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$25.66M 10-Q · filed 2026-05-07 | -$42.15M derived: sum of 2 quarters · filed 2026-05-07 | -$62.72M derived: sum of 3 quarters · filed 2026-05-07 | -$96.05M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$16.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$37.06M derived: sum of 2 quarters · filed 2026-02-13 | -$70.39M derived: sum of 3 quarters · filed 2026-02-13 | -$116.30M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$20.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$53.90M derived: sum of 2 quarters · filed 2025-11-10 | -$99.81M 10-Q · filed 2025-11-10 | -$124.26M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$33.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$79.25M 10-Q · filed 2025-08-07 | -$103.69M derived: sum of 3 quarters · filed 2026-02-13 | -$137.69M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$45.91M 10-Q · filed 2025-05-08 | -$70.35M derived: sum of 2 quarters · filed 2026-02-13 | -$104.35M derived: sum of 3 quarters · filed 2026-02-13 | -$132.53M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$24.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$58.44M derived: sum of 2 quarters · filed 2026-02-13 | -$86.62M derived: sum of 3 quarters · filed 2026-02-13 | -$131.37M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$34.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$62.17M derived: sum of 2 quarters · filed 2024-11-07 | -$106.93M 10-Q · filed 2024-11-07 | -$141.44M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$28.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$72.93M 10-Q · filed 2024-08-08 | -$107.44M derived: sum of 3 quarters · filed 2025-02-28 | -$141.75M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$44.76M 10-Q · filed 2024-05-09 | -$79.26M derived: sum of 2 quarters · filed 2025-02-28 | -$113.58M derived: sum of 3 quarters · filed 2025-02-28 | -$152.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$34.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$68.82M derived: sum of 2 quarters · filed 2025-02-28 | -$107.39M derived: sum of 3 quarters · filed 2025-02-28 | -$145.73M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$34.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$72.89M derived: sum of 2 quarters · filed 2023-11-08 | -$111.22M 10-Q · filed 2023-11-08 | -$143.90M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$38.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$76.91M 10-Q · filed 2023-08-03 | -$109.59M derived: sum of 3 quarters · filed 2024-02-21 | -$137.72M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$38.34M 10-Q · filed 2023-05-04 | -$71.01M derived: sum of 2 quarters · filed 2024-02-21 | -$99.14M derived: sum of 3 quarters · filed 2024-02-21 | -$129.98M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$32.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$60.81M derived: sum of 2 quarters · filed 2024-02-21 | -$91.65M derived: sum of 3 quarters · filed 2024-02-21 | -$130.26M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$28.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$58.97M derived: sum of 2 quarters · filed 2022-11-09 | -$97.59M 10-Q · filed 2022-11-09 | -$123.43M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | -$30.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$69.46M 10-Q · filed 2022-08-02 | -$95.30M derived: sum of 3 quarters · filed 2023-02-13 | -$124.41M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | -$38.62M 10-Q · filed 2022-05-05 | -$64.46M derived: sum of 2 quarters · filed 2023-02-13 | -$93.57M derived: sum of 3 quarters · filed 2023-02-13 | -$112.74M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | -$25.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | -$54.96M derived: sum of 2 quarters · filed 2023-02-13 | -$74.12M derived: sum of 3 quarters · filed 2023-02-13 | -$99.02M 10-K · filed 2023-02-13 |
| 2020-09-30 | -$29.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$48.28M derived: sum of 2 quarters · filed 2021-11-04 | -$73.17M 10-Q · filed 2021-11-04 | -$88.37M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | -$19.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$44.06M 10-Q · filed 2021-08-06 | -$59.25M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2020-03-31 | -$24.89M 10-Q · filed 2021-05-06 | -$40.09M derived: sum of 2 quarters · filed 2022-02-23 | ||
| 2019-12-31 | -$15.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$70.29M 10-K · filed 2022-02-23 | ||
| 2019-09-30 | -$55.10M 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | -$46.44M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |